Our CEO Kenichi Kono to speak at Nikkei BP's Cross Health EXPO 2019

Kenichi Kono, physician and Representative Director and CEO of iMed Technologies, Inc. (headquartered in Shibuya-ku, Tokyo), which develops surgical support AI for ischemic stroke and subarachnoid hemorrhage, will speak at a theater session (“Medical x AI 2020 — The Use of AI in Clinical Settings Advancing into 2020”) of Nikkei BP’s Cross Health EXPO 2019, held at Tokyo Big Sight for three days from Wednesday, October 9 to Friday, October 11, 2019.

See the following link for event details. https://ers.nikkeibp.co.jp/user/contents/2019z1009xhe/index.html#HT_HT-31D

■iMed Technologies, Inc. Company Profile Company name: iMed Technologies, Inc. Address: 5F Eclat Shibuya, 3-6-2 Shibuya, Shibuya-ku, Tokyo Founded: April 1, 2019 Business: Development of surgical support AI for ischemic stroke and subarachnoid hemorrhage Representatives: Representative Director and CEO, physician Kenichi Kono Representative Director and COO, Motohisa Kaneko

■Inquiries regarding this release Email: info@imed-tech.co.jp